Overview
The Clinical Trials Information System (CTIS) is the backbone of the Clinical Trials Regulation (Regulation (EU) No 536/2014) and acts as a the single-entry point for clinical trials assessment, authorisation and supervision in the EEA.
It also enables the publication and registration of clinical trials in the CTIS public website that is a public register with search and download functionalities.
CTIS provides harmonised and simplified end-to-end electronic application procedures over the lifecycle of clinical trials across the EU/EEA.
Since the launch of CTIS on 31 January 2023, only 15 months remain to transition ongoing trials from the previous legislative framework of the Clinical Trials Directive (2001/20/EC) to the Clinical Trial Regulation (536/2014).
The virtual event aims to support sponsors of clinical trials in preparing and proceeding with the transition to meet the deadline of 30 January 2025. Commercial and non-commercial sponsors with experience in transitioning trials as well as representatives from EMA and EU/EEA member states will share insights and best practices.
Ample time is foreseen for Q&A. The faculty invites participants to submit related questions by 03 October 2023 latest to emaevents@diaglobal.org
Program Committee
-
Peter Richard Arlett, MD, FFPM, FRCP Head Data Analytics and Methods Task Force
European Medicines Agency, Netherlands -
Marianne Lunzer, DrMed Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
AGES, Austria -
Noemie Manent, PharmD TDA-CTT Operations Workstream Lead
European Medicines Agency, Netherlands
Have an account?